Company profile
Anteris Technologies Global Corp.
NASDAQ: AVR · Healthcare · Medical - Devices
PublicHQ Toowong, QLDCIK 0002011514Reports USD
#808 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
32DFH 33DQ 26GM —SS 52
v0.1 · 55/100 weight · provisional
↑ Altman-Z, market scale · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
-25.7%
Net income (FY)
-$94.1M
Employees
174
as of 2026-09-01
Market cap
$837.2M
as of 2026-09-01
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.9M$1.9M2025
Net income-$94.1M-$94.1M2025
Operating income-$93.9M-$93.9M2025
Total assets$23.0M$23.0M2025
Liabilities$23.3M$23.3M2025
Equity-$93.0k-$93.0k2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Anteris Technologies Global Corp.’s revenue?
Anteris Technologies Global Corp. booked $1.9M in FY2025 revenue, contracting 29% year over year — slower than 75% of Healthcare companies we track, at a -4921.3% net margin.
Peers · Healthcare
Lipocine Inc.48DTHC Biomed Intl Ltd.——iSpecimen Inc.29DLongevity Health Holdings Inc.22DVeltex Corporation50DBio Essence Corporation52DKey facts
CEOWayne Geoffrey Paterson
SectorHealthcare
IndustryMedical - Devices
HeadquartersToowong, QLD
ExchangeNASDAQ: AVR
Employees174
IPO date2024-12-13
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.